High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: A retrospective investigation on 133 patients treated in a single institution-Reference-Cited by-同舟云学术

High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: A retrospective investigation on 133 patients treated in a single institution

Published:2011-08-17 Issue:9 Volume:86 Page:762-767
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Azzarà Antonio,Carulli Giovanni,Galimberti Sara,Baratè Claudia,Fazzi Rita,Cervetti Giulia,Petrini Mario

Publisher

Wiley

Subject

Hematology

Reference46 articles.

1. Myelodysplastic syndromes: Clinical features;Hoffman;Semin Hematol,1996

2. Myelodysplastic syndromes;List;Hematol-Am Soc Hematol Education Program,2004

3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

4. Prognostic evaluation of myelodysplastic syndromes (MDS): Analysis of deaths due to age-related causes;Salvi;Blood,2005

5. Efficacy of erithropoietin in the myelodysplastic syndromes: A meta-analysis of 205 patients from 17 studies;Hellström-Lindberg;Br J Haematol,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Literature Review of Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes;Journal of Clinical Medicine;2024-05-04

2. Myelodysplastic syndromes: a review of therapeutic progress over the past 10 years;Expert Review of Anticancer Therapy;2020-06-01

3. Myelodysplastic Syndromes;PharmacotherapyFirst: A Multimedia Learning Resource;2017-05

4. Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study;Annals of Hematology;2014-03-20

5. High-dose recombinant human erythropoietin for "low-risk" myelodysplastic patients: is more better?;CHIN CLIN ONCOL;2012